Lupus Erytematous Syndrome and Anti Phospolipid Syndrome in a 44-Year-Old Man
DOI:
https://doi.org/10.55324/josr.v4i7.2671Keywords:
Anti Phospolipid Syndrome, Sistemik Lupus EritematousAbstract
Antiphospholipid syndrome (APS) is a blood clotting condition characterized by thrombosis and obstetric disorders, more common in women. This case is rarely found in men due to vague symptoms. We reported a 34-year-old male patient who was admitted to Ulin Hospital on April 6, 2022 with complaints of headache, joint pain, and a history of autoimmune disorders. The patient develops cerebrovascular conditions at a young age. The diagnosis is made based on an anamnesis, physical examination, laboratory, and CT Scan, which shows Systemic Lupus Erytematous with APS. Laboratory results showed increased leukocytes, cholesterol, and coagulation, as well as high anticoagulant lupus. The therapies provided include methyl prednisolone, hyloquin, Myfortic, and the anticoagulant warfarin with a target of INR 2-3. The manifestations of APS and Lupus Erytematous vary, so a proper clinical approach is required. The diagnosis of APS in men is often overlooked due to the lack of obvious obstetric symptoms. Without supporting examinations, treatment cannot be carried out effectively, which can worsen the patient's condition. Patients are required to routinely monitor INR for anticoagulants, and evaluations are required for laboratory examinations to prevent economic losses.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Aqsha Tiara Viazelda, I Nyoman Suarjana

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


